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Here is proposed a rapid and sensitive method involving atmospheric pressure thermal desorption
chemical ionization mass spectrometry (APTDCI-MS) for specific laboratory screening of the Smith–
Lemli–Opitz syndrome (SLOS), an inherited defect of cholesterol biosynthesis. Biochemical findings in
the blood of SLOS patients are low cholesterol (Chol), high 7- and 8-dehydrocholesterol (DHCs) levels
and high DHCs/Chol ratios. The APTDCI proposed method is able to ionize sterols for qualitative and
quantitative analysis directly from dried plasma/blood spots. Critical APTDCI parameters –
desolvation gas flow and temperature – were optimized analyzing Chol, 7-DHC and cholesteryl stearate
standards spotted onto a glass slide acquiring the full scan spectra in positive ion mode. Chol levels in
dried plasma spots of unaffected controls (n ¼ 23) obtained by the proposed method were compared
with those of the enzymatic method (y ¼ 0.9166x + 0.3811; r ¼ 0.8831) while Chol and DHCs of SLOS
patients (n ¼ 9) were compared with the gas chromatography flame ionization detection (GC-FID)
method (y ¼ 0.8214x + 0.7388; r ¼ 0.8288). The APTDCI-MS method is also able to differentiate
normal from SLOS samples directly analyzing whole blood and washed red cells spotted on paper. In
conclusion, the intrinsic analytical high-throughput of APTDCI-MS method for sterol analysis could
be useful to screen SLO syndrome.
Introduction
Smith–Lemli–Opitz Syndrome (SLOS; OMIM 270400) is an
autosomal recessive multiple malformation syndrome with a very
broad phenotypic spectrum. Infants affected by the severe form
typically die in the perinatal period while the milder variant
causes distinct behavioural and learning problems, growth
failure and intellectual disability.1–3 The discovery of the defi-
ciency of sterol delta7-reductase as a causative factor of SLOS
made this syndrome the first true metabolic syndrome of multiple
congenital malformations.4 Several mutations in the human gene
sterol delta7-reductase (DHCR7) are implicated in the syndrome
causing the deficiency of the enzyme activity (DHCR7; EC
1.3.1.21) which catalyzes the last step of cholesterol biosyn-
thesis,5–8 resulting in low plasma cholesterol and increased 7- and
8-dehydrocholesterol (7-DHC, 8-DHC) levels. The worldwide
incidence of SLOS is variable and difficult to estimate accurately:
it ranges from 1/20 000 to 1/70 000 and is more common in
Northern European individuals.9 Analysis by GC-MS of
cholesterol and DHCs levels in blood, tissues or cells is the
reference method for the diagnosis of SLOS;4 also the prenatal
diagnosis can be made by measuring the sterols in amniotic fluid
or chorionic villus cells.10 Analysis of sterols by GC/MS also
allows the identification of the rare SLOS-like syndromes such as
lathosterolosis and desmosterolosis.11,12 On the other hand, GC-
MS is time-consuming because of the long time of both sample
clean up and chromatographic analysis, so several attempts to
use other MS techniques have been done. To date, a fast
screening method for the diagnosis of these syndromes is lacking.
Recently, different ambient desorption ionization (ADI)
techniques have been introduced to analyze many compounds by
direct sampling/ionization of the analytes from raw samples
providing a stimulating concept of MS analysis without sample
preparation which could lead to the development of high-
throughput analysis.13 ADI techniques are mainly based on two
fundamental principles described by Cooks et al. and by Cody
et al. named desorption electrospray ionization (DESI)14,15 and
direct analysis in real time (DART),16 respectively. ADI has been
used to perform analysis in different fields for biological,17–20
forensic21,22 and pharmaceutical applications.23–25 Nevertheless,
the quantitative performance of ADI techniques has not yet been
sufficiently investigated, even if Ifa et al. demonstrate that DESI-
MS systems can provide good quantitative response when an
internal standard is used.26 Moreover, compounds with a lower
proton affinity, such as sterols, are difficult to ionize with the
ambient ionization and only few ADI methods have been
reported for the analysis of these compounds.
Recently, Wu et al. successfully developed a reactive-DESI
method for the analysis of free cholesterol in human serum,27
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while McEwen and Gutteridge developed a technique named
atmospheric solids analysis probe (ASAP)28 which has been
employed for the desorption/ionization of a variety of sterols
from liquids, solids and biological tissues. In this study a tech-
nique based on atmospheric pressure thermal desorption chem-
ical ionization (APTDCI), previously described by us,29 has been
employed to analyze sterols. In both ASAP and APTDCI
methods the heated nitrogen desolvation gas, from either an ESI
or APCI probe, has been employed as vaporization source. The
ionization of the thermally induced vapors occurs by corona
discharge under standard APCI conditions. In the APTDCI
technique the solid sample is positioned on a sample holder near
the ion source region and analyzed in its native form, while in
ASAP the sample must be introduced into a capillary melting
point tube before the analysis. Moreover, APTDCI does not
need source modification because the sample holder can be easily
inserted into the ionization chamber.
In this work the sterols are desorbed and ionized directly from
dried plasma/blood spotted on paper for neonatal screening
using APTDCI and quantitatively analyzed by MS. The devel-
oped APTDCI-MS method is able to differentiate unaffected
subjects from SLOS patients. The dried spot samples offer
significant advantages such as simple sample collection, less
invasive nature and no risks associated with the use and disposal
of needles and syringes.30 Besides, dried sample spots, adequately
stored, can be long-term archived.31,32
Experimental
Materials and reagents
The analytical solvents of HPLC grade, methanol, n-hexane,
acetone, ethanol, 2-propanol and chloroform, were obtained
from J.T.Baker (Deventer, Netherlands). NaCl 0.9% was from
Bieffe Medital (Grosotto, Sondrio, Italy). KOH was purchased
from Merck (Merck KGaA, Darmstadt, Germany). 5a-Choles-
tane, cholesterol (Chol), 7-dehydrocholesterol (7-DHC), lath-
osterol, sitosterol and cholesteryl stearate (C18:0 CE) standards
were purchased from Sigma Aldrich Ltd. (St. Louis, MO, USA).
The labeled internal standard (IS), cholesterol-26,26,26,27,27,27-
d6 (d6-Chol; 97–98%), was purchased from C/D/N Isotopes Inc.
(Quebec, Canada).
Chol, 7-DHC, sitosterol, C18:0 CE and d6-Chol standards
were prepared as stock solutions of 1 g/L in ethanol–2-propanol
(7:3) and stored at "20 #C until the analysis by APTDCI-MS. A
working solution forMS tuning containing not labeled standards
(Chol, 7-DHC and C18:0 CE) was prepared in chloroform.
For gas chromatography/flame ionization detector (GC/FID)
analysis, 5a-cholestane (IS), Chol, 7-DHC, lathosterol and
sitosterol standards were dissolved in a chloroform–methanol
mixture (2:1, v/v) to a final concentration of 1 g/L and stored at
"20 #C.
Samples and patients
Plasma samples (n ¼ 23) from apparently healthy subjects and
with cholesterol ranging from 100 to 300 mg/dL were anony-
mously selected from those routinely analyzed in the Clinical
Biochemistry Laboratory of Foggia Hospital. Samples from
SLOS patients, plasma (n ¼ 9) and whole blood (n ¼ 2), were
selected from those collected at the diagnostic Laboratory of
Department of Biochemistry and Medical Biotechnologies of
Naples. A few drops of whole blood were directly spotted onto
paper, then plasma and blood red cells were obtained following
standard separation procedures; after centrifugation the plasma
was recovered and used for the preparation of the spots. In order
to remove the excess of plasma, blood red cells were washed three
times with NaCl solution (0.9%) and spotted onto paper. All
spots were dried and stored protected from light at 4 #C until the
analysis by APTDCI-MS for the qualitative evaluation. All
plasma samples were stored at "20 #C.
For quantitative analysis, d6-Chol was used as internal
standard. The calibration curves were prepared following two
different procedures to add the internal standard to the samples.
Calibrators containing Chol and 7-DHC standards were
prepared at the following levels: 0, 0.90, 2.3, 3.2 and 5.2 mM for
Chol; 0, 0.21, 0.42, 0.83 and 1.66 mM for 7-DHC. These cali-
brators were divided into two groups (A and B) and 5 mL of
internal standard (1.02 mM) were added only to group A. Both
groups were dried using a sample concentrator dry-block
(DB-3D, Techne, Cambridge, UK), then resuspended by adding
50 mL of plasma and mixed vigorously. 25 mL from each cali-
bration point of group A and 25 mL from each calibration point
of group B were spotted onto paper separately and allowed to
dry. The blank was prepared by spotting NaCl 0.9% containing
the same amount of internal standard for the group A and
without internal standard for the group B. Disks of 6 mm (B)
punched from dried plasma spots of group A were directly
analyzed by APTDCI-MS, while 5 mL of internal standard
(1.02 mM) were added to the disks punched from dried plasma
spots of group B before analysis by APTDCI-MS. Each point of
both calibration curves was prepared in triplicate. The dried
plasma spots from group B were employed for the quantitative
study.
Analytical procedure
APTDCI-MS. A triple quadrupole mass spectrometer
(Micromass QuattroMicro, Waters-USA) was equipped with
a home-made APTDCI device previously described.29 The
geometry of the system was evaluated using standard solutions
spotted onto glass slides (Chol 52 pmol, 7-DHC 52 pmol and
C18:0 CE 31 pmol). The sprayer–surface distance and MS inlet–
sample distance were set at about 14 mm and 1 mm, respectively.
The collection angle between the MS inlet and sample was of 20#
and the incidence angle between the sprayer and sample was of
82#. The spectra were acquired in positive ion mode scanning
a mass range from 350 to 450 m/z, the scan time and interscan
delay were of 1 s and 0.1 s, respectively. The cone voltage, the
source temperature, the desolvation gas flow, the desolvation gas
temperature and the nebulizer gas pressure were set at 20 V,
150 #C, 450 L/h, 500 #C and 80 psi, respectively. During the
APTDCI process, the analytes were desorbed by heated nitrogen
gas flow and the ionization was induced by a corona discharge
(2 mA). No solvent was sprayed during the APTDCI
experiments.
GC/FID analysis. A gas chromatograph (HP-5890; Agilent
Laboratories, CA, USA) equipped with a SAC-5 capillary
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column (30 m length, 0.25 mm I.D., 0.25 mm film thickness;
Supelco, Germany) was used to separate the sterols using
nitrogen as a carrier gas with a column flow rate of 25 cm/s and
a total flow rate of 20 mL/min. The head column gas pressure was
19.5 psi. The total run time was 25 min using a constant oven
temperature of 280 #C and a constant injector and detector
temperature of 300 #C. The retention times (tR) of chromato-
graphic peaks obtained from plasma samples were compared
with those obtained from standard compounds. The relative
retention time (RtR) of each peak, compared to 5a-cholestane,
was 1.55 for cholesterol, 1.58 for 8-DHC, 1.67 for 7-DHC, 1.72
for lathosterol and 2.23 for sitosterol. Sterol concentrations were
obtained by interpolating the peak area ratios (analyte/IS) on the
calibration curves. A plasma pool with a cholesterol concentra-
tion of 142 mg/dL was spiked with 7-DHC, lathosterol and
sitosterol standards at a final concentration of 50 mg/dL,
respectively, and used for the calibration curves, the solution was
diluted with NaCl (0.9%) and spotted onto paper to prepare
different calibration points. The analysis of total sterols from
calibrators and patient samples was performed using sample
spots of 6 mm (B) and 40 mg of internal standard (5a-choles-
tane); then 3 mL of 1 NKOH in 90% ethanol were added and the
mixture was incubated for 60 min at 80 #C. After the hydrolysis,
the samples were mixed with 3 mL of distilled water and
extracted three times with 3 mL of hexane. The upper organic
phases were pooled and evaporated under a gentle stream of
nitrogen at 40 #C. The dry residue was dissolved with 100 mL of
dichloromethane; 1 mL of the solution was injected into the
GC/FID.
8-DHC concentrations of SLOS patients were calculated using
the calibration curve of 7-DHC because the 8-DHC standard is
not commercially available.32
Enzymatic method. Total cholesterol of plasma samples from
healthy subjects was analyzed by the enzymatic method based on
cholesterol esterase/cholesterol oxidase (ILAB-600; Instrumen-
tation Laboratory, MA, USA).
Statistical analysis. The Pearson correlation coefficient and
simple regression analysis were used to correlate the results of the
proposed method with the enzymatic and the GC/FID methods.
Results and discussion
The aim of this work is to demonstrate that the APTDCI-MS
method offers a simple tool to screen quickly the Smith–Lemli–
Opitz syndrome, analyzing directly a dried sample spot without
sample preparation. The diagnostic metabolites of SLOS – Chol,
7- and 8-DHC – are difficult to ionize using DESI and here it is
demonstrated that the desorption/ionization mechanism of the
APTDCI technique is suitable for analysis of the sterols. In Fig. 1
the procedure employed to perform the analysis on dried samples
by APTDCI device inserted in the ionization chamber is depicted
step by step.
In Fig. 2 are shown the APTDCI-MS spectra obtained from
standard solutions of Chol, 7-DHC and C18:0 CE spotted onto
the glass slide. During the analysis of Chol the thermal desorp-
tion mechanism promotes the formation of cholestadiene, then it
is suddenly protonated using corona discharge (Fig. 2a). This
mechanism also causes the desorption/ionization of other sterols
and of cholesteryl esters. As shown, the APTDCI analysis of
both Chol and C18:0 CE produces the same ion at m/z 369
resulting from the loss of water (Fig. 2a) or from the loss of the
fatty acid (Fig. 2c), while the 7-DHC produces the ion at m/z 367
(Fig. 2b). The monitoring of the cholestadiene ion, produced
from both cholesterol and cholesteryl ester, allows the determi-
nation of total cholesterol without any pre-analytical step to
convert cholesteryl esters into free cholesterol. Also, other free
sterols and their esters can be detected as one signal corre-
sponding to the mass of sterol less water or acyl chain (data not
shown).
The influence of the temperature on the signal intensity of
Chol and 7-DHC was also investigated by maintaining the des-
olvation gas flow constant at 450 L/h and varying the des-
olvation gas temperature from 100 to 600 #C. The signal
intensity for both Chol and 7-DHC increased with the temper-
ature, achieving the optimum at 500 #C (Fig. 3). APTDCI is
similar to the desorption atmospheric pressure chemical ioniza-
tion technique (DAPCI),33 but in DAPCI a solvent is sprayed
through the capillary nebulizer gas to facilitate the desorption/
ionization of compounds. In Fig. 3 is depicted the ionization
efficiency of APTDCI compared to DAPCI analysis performed
spraying a mixture of water–methanol (1:1) at the flow rate of
10 mL/min and using the same APTDCI parameters set up. The
solvent employed in the DAPCI technique does not improve the
desorption/ionization response.
Qualitative analysis
The qualitative response of diagnostic sterols during the
APTDCI-MS process was investigated using three different
complex matrices – plasma, washed red cells and whole blood –
spotted onto paper. As represented in Fig. 4, looking at the full
scan spectra, it is possible to distinguish between normal and
SLOS. In fact, the SLOS spectra display a reduction of the
cholesterol ion intensity (m/z 369) and an increase of the DHCs
ion intensity (m/z 367). The ion at m/z 367 is well resolved
from that of cholesterol and it represents the sum of 7-DHC and
8-DHC.
Fig. 1 APTDCI-MS analysis procedure steps.
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The DHCs ion intensity in SLOS samples is about 20%
compared to the Chol ion intensity. Instead, in control samples
the ion intensity at m/z 367 is less than 2% compared to Chol.
Measuring this signal, which represents the sum of both isomers,
the diagnosis of SLOS is not missed, even if caution should be
given for blood samples stored on paper for long periods.32 In
addition, lower cholesterol and higher DHCs lead to an increase
of the DHCs/Chol ratio which could improve the diagnostic
Fig. 2 APTDCI-MS spectra obtained spotting 2 mL of standard solutions of cholesterol (a), 7-dehydrocholesterol (b) and cholesteryl stearate (c) on
glass slides.
Fig. 3 Influence of desolvation gas temperature on the signal intensity of cholesterol and 7-dehydrocholesterol during APTDCI-MS and DAPCI-MS
experiments (desolvation gas flow is constant at 450 L/h).
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sensitivity compared to the measurement of DHCs concentra-
tion. Plasma concentrations of cholesterol isobars, such as
lathosterol, are very low (less than 0.3% of total cholesterol) and
normally do not influence the analysis of Chol significantly.34 In
Fig. 4c is also depicted the full scan spectrum obtained by the
APTDCI-MS analysis of a dried plasma spot from a positive
control spiked with 7-DHC, internal standard and sitosterol.
Sitosterol is also measurable by this method as the ion at m/z 397
after the loss of water; this compound has been confirmed by
tandem MS analysis (data not shown).
A specificity study was conducted to confirm the identity of
Chol and DHCs; they were analyzed by a collision induced
dissociation study (the mass range was from m/z 50 to 400; the
collision energy was 25 eV); the fragmentation spectra are shown
in Fig. 5. The product ion spectra of m/z 369 and 367 obtained
from standards (panels a and c) compared to the product ion
spectra of Chol and of DHCs from a dried spot of a SLOS
patient (panels b and d) are well overlapped.
In Table 1 the DHCs/Chol ratio of two SLOS patients by
APTDCI-MS, calculated using the ion intensity, are compared
with those obtained by GC/FID. The results of the patient #1
provide similar ratios, while the APTDCI-MS ratios of patient
#2 are lower than those of the GC/FID method – this compar-
ison should be improved by analyzing a consistent number of
patients to obtain more significant results. The CV% obtained
from 3 separate experiments did not exceed 10% for both
APTDCI-MS and GC/FID methods.
Quantitative analysis
Internal standard. The use of the internal standard is critical for
the quantitative analysis by ambient desorption ionization as
reported previously.27,35,36 In this study the possibility of adding
the internal standard to the dried plasma spot has been evaluated
by preparing two calibration curves using dried plasma spots
containing internal standard (group A) and dried plasma spots
without internal standard (group B). The disks obtained from
dried plasma spots containing the internal standard (group A)
were directly analyzed by APTDCI-MS, while the disks obtained
from dried plasma spots without the internal standard (group B)
were spiked with 5 mL of internal standard before the analysis.
The comparison of both calibration curves, for the range of
cholesterol concentrations employed in this study, shows a good
linearity providing the following equations: y¼ 2.4176x" 0.9749
and r ¼ 0.9695 (group A), y ¼ 0.6587x + 0.1110 and r ¼ 0.9944
(group B). These data demonstrate that the internal standard can
be directly spotted onto the dried spot; in fact, this procedure
shows a better calibration response compared to the addition of
the internal standard in solution before the preparation of the
spots. The internal standard is essential for the quantitative
Fig. 4 APTDCI-MS spectra obtained from dried plasma spots, dried blood spots and dried red cells spots of negative and positive controls and SLOS
samples.
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analysis and the possibility of adding it directly to dried spots
enables APTDCI-MS as a screening method to analyze dried
plasma/blood spots collected at different times and places. The
collection of dried blood spots on filter paper is less invasive for
the patient and has significant advantages due to the samples’
longer lifespan with the reduced need for refrigeration; it is simple
to perform, requiresminimal training, and the samples are easy to
ship. In addition there are economic benefits; in fact, the transport
and the laboratory handling of dried spots are considerably
cheaper than samples collected by venipuncture.30
Comparison between methods. The concentrations of Chol and
DHCs in dried plasma spot of patients and healthy subjects were
calculated using the calibration curves obtained by analyzing
calibrators of group B (Chol: y¼ 0.6587x + 0.1110, r¼ 0.9944; 7-
DHC: y ¼ 0.1801x + 0.0895; r ¼ 0.9969).
Cholesterol plasma levels in healthy subjects (n ¼ 23)
measured by APTDCI-MS were compared with those obtained
by the enzymatic method. As depicted in Fig. 6a the comparison
between the two methods shows a significant linear correlation
(r ¼ 0.8831; y ¼ 0.9166x + 0.3811) even if the value of the
intercept, due to a high baseline noise of the full scan spectra,
influences positively the concentrations obtained by APTDCI-
MS.Moreover, Chol and DHCs levels obtained by APTDCI-MS
from SLOS samples (n ¼ 9) were compared with those analyzed
by GC/FID (Fig. 6b): although the number of data pairs are few,
the correlation is also significant (r ¼ 0.8288; y ¼ 0.8214x +
0.7388) and the value of intercept is positive too.
The ranges of the DHCs/Chol ratio of both APTDCI-MS and
GC/FID methods are shown in Table 2; they were calculated
from concentrations (mM) of 32 dried plasma spots (normal
n ¼ 23; SLOS n ¼ 9). The DHCs/Chol ratio by APTDCI-MS
ranged from 0.01 to 0.17 for normal samples and from 0.26 to
Fig. 5 APTDCI-MS/MS product ion spectra obtained from standard solutions of cholesterol (a) and 7-DHC (c) and from cholesterol (b) andDHCs (d)
of a SLOS dried blood spot.
Table 1 Comparison of DHCs/Chol ratio obtained from dried blood
spots, dried red cells spots and dried plasma spots of two SLOS samples
analyzed by APTDCI-MS and GC/FID methods
Matrix
DHCs/Chola
APTDCI-
MS CV (%) GC/FID CV (%)
SLOS
sample (#1)
Dried blood spot 0.22 10 0.28 10
Dried red cells spot 0.19 8 0.27 4
Dried plasma spot 0.20 7 0.26 10
SLOS
sample (#2)
Dried blood spot 0.31 2 0.63 10
Dried red cells spot 0.36 10 0.72 9
Dried plasma spot 0.53 2 0.81 5
a The ratio DHCs/Chol was calculated using the signal intensity (n ¼ 3)
of the ions obtained from the spectra.
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1.59 for SLOS samples (Table 2). These ranges are not over-
lapped and allow us to distinguish affected patients from normal
subjects. Even if the proposed method is able to differentiate
normal from SLOS samples, it is evident that the DHCs/Chol
ratio obtained by APTDCI-MS is influenced by the baseline
noise and the dynamic range of the MS method is narrower than
by GC-FID. In this method all APTDCI-MS spectra were
acquired using the full scan mode. In particular, the results in
normal samples show that the high background influences the
concentrations of DHCs more than those of cholesterol; then,
the noise observed by APTDCI-MS increases the DHCs/Chol
ratios of normal samples which are significantly higher than
those of the GC/FID method (Table 2).
Further experiments using a higher number of SLOS patients
and by tandem mass spectrometry coupled to the APTDCI
technique need to be done to improve the dynamic range and
background noise.
Conclusions
The advantages of the ADI techniques and the ability to ionize
more lipophilic compounds, such as cholesterol, make the
proposed APTDCI-MS method a useful tool that could be
potentially used to screen the SLO syndrome, determining the
DHCs and Chol levels and the DHCs/Chol ratios in proband
patients. The method is also able to detect sitosterol, a diagnostic
marker of sitosterolemia, a rare autosomal recessively inherited
disorder of sterol transport characterized by hypercholesterol-
emia and hypersitosterolemia;37 moreover, it is potentially able
to differentiate other metabolic disorders of sterols.
This is the first report in which sterols are quickly analyzed
directly on dried plasma/blood spots, without sample prepara-
tion, providing qualitative and quantitative results acceptable for
the screening of SLOS in less than 3 min; moreover, the closed
ionization chamber guarantees the operator’s safety.
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